HEADER SUGAR BINDING PROTEIN 16-AUG-17 6AOY TITLE F9 PILUS ADHESIN FMLH LECTIN DOMAIN FROM E. COLI UTI89 CO-CRYSTALLIZED TITLE 2 WITH O-NITROPHENYL BETA-GALACTOSIDE (ONPG) COMPND MOL_ID: 1; COMPND 2 MOLECULE: FML FIMBRIAL ADHESIN FMLD; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 364106; SOURCE 4 STRAIN: UTI89 / UPEC; SOURCE 5 GENE: FMLD, UTI89_C1716; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C600 KEYWDS FIMBRIAL ADHESIN, LECTIN, BACTERIAL ADHESION, SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR V.KALAS,S.J.HULTGREN REVDAT 5 30-OCT-24 6AOY 1 REMARK REVDAT 4 04-OCT-23 6AOY 1 HETSYN REVDAT 3 29-JUL-20 6AOY 1 COMPND REMARK HETNAM SITE REVDAT 3 2 1 ATOM REVDAT 2 11-SEP-19 6AOY 1 JRNL REVDAT 1 28-FEB-18 6AOY 0 JRNL AUTH V.KALAS,M.E.HIBBING,A.R.MADDIRALA,R.CHUGANI,J.S.PINKNER, JRNL AUTH 2 L.K.MYDOCK-MCGRANE,M.S.CONOVER,J.W.JANETKA,S.J.HULTGREN JRNL TITL STRUCTURE-BASED DISCOVERY OF GLYCOMIMETIC FMLH LIGANDS AS JRNL TITL 2 INHIBITORS OF BACTERIAL ADHESION DURING URINARY TRACT JRNL TITL 3 INFECTION. JRNL REF PROC.NATL.ACAD.SCI.USA V. 115 E2819 2018 JRNL REFN ESSN 1091-6490 JRNL PMID 29507247 JRNL DOI 10.1073/PNAS.1720140115 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 27375 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1376 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.8357 - 3.8761 1.00 2654 151 0.1630 0.2031 REMARK 3 2 3.8761 - 3.0773 1.00 2620 154 0.1671 0.2051 REMARK 3 3 3.0773 - 2.6885 1.00 2606 129 0.1979 0.2311 REMARK 3 4 2.6885 - 2.4428 1.00 2588 145 0.1995 0.2300 REMARK 3 5 2.4428 - 2.2678 1.00 2629 137 0.1896 0.1874 REMARK 3 6 2.2678 - 2.1341 1.00 2567 129 0.1886 0.2244 REMARK 3 7 2.1341 - 2.0272 1.00 2609 137 0.1844 0.2187 REMARK 3 8 2.0272 - 1.9390 0.99 2591 148 0.2004 0.2742 REMARK 3 9 1.9390 - 1.8643 0.99 2579 123 0.2332 0.3019 REMARK 3 10 1.8643 - 1.8000 0.98 2556 123 0.2589 0.2993 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.840 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2439 REMARK 3 ANGLE : 0.870 3342 REMARK 3 CHIRALITY : 0.030 381 REMARK 3 PLANARITY : 0.003 425 REMARK 3 DIHEDRAL : 11.591 831 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AOY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1000229603. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27380 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 40.030 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.67800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6AOW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE, 0.1M NACL, 0.1 REMARK 280 M MES PH 5.6, 32% PEG 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 33.11000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 39.16000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 33.11000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 39.16000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 358 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 382 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 422 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 433 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 111 REMARK 465 GLY A 112 REMARK 465 ALA A 113 REMARK 465 ALA A 114 REMARK 465 THR A 158 REMARK 465 GLY A 159 REMARK 465 GLY A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 465 HIS A 163 REMARK 465 HIS A 164 REMARK 465 HIS A 165 REMARK 465 HIS A 166 REMARK 465 THR B 158 REMARK 465 GLY B 159 REMARK 465 GLY B 160 REMARK 465 HIS B 161 REMARK 465 HIS B 162 REMARK 465 HIS B 163 REMARK 465 HIS B 164 REMARK 465 HIS B 165 REMARK 465 HIS B 166 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 30 CG CD OE1 NE2 REMARK 470 GLN A 68 CG CD OE1 NE2 REMARK 470 GLN B 30 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH1 ARG B 127 O HOH B 301 1.99 REMARK 500 O HOH B 383 O HOH B 412 2.05 REMARK 500 O HOH A 332 O HOH A 403 2.12 REMARK 500 O HOH B 358 O HOH B 416 2.14 REMARK 500 O HOH A 308 O HOH A 378 2.18 REMARK 500 O HOH A 411 O HOH A 416 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 50 -73.91 -65.15 REMARK 500 ASP A 51 70.07 -104.78 REMARK 500 GLN A 59 129.39 -39.46 REMARK 500 SER A 66 -74.96 130.59 REMARK 500 ASP B 51 77.79 -113.17 REMARK 500 GLN B 59 133.26 -39.80 REMARK 500 ALA B 114 87.92 34.60 REMARK 500 REMARK 500 REMARK: NULL DBREF 6AOY A 1 160 UNP Q1RBS0 Q1RBS0_ECOUT 25 184 DBREF 6AOY B 1 160 UNP Q1RBS0 Q1RBS0_ECOUT 25 184 SEQADV 6AOY HIS A 161 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS A 162 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS A 163 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS A 164 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS A 165 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS A 166 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 161 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 162 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 163 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 164 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 165 UNP Q1RBS0 EXPRESSION TAG SEQADV 6AOY HIS B 166 UNP Q1RBS0 EXPRESSION TAG SEQRES 1 A 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 A 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 A 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 A 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 A 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 A 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 A 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 A 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 A 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 A 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 A 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 A 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 A 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS SEQRES 1 B 166 PHE SER CYS ASN VAL ASP GLY GLY SER SER ILE GLY ALA SEQRES 2 B 166 GLY THR THR SER VAL TYR VAL ASN LEU ASP PRO VAL ILE SEQRES 3 B 166 GLN PRO GLY GLN ASN LEU VAL VAL ASP LEU SER GLN HIS SEQRES 4 B 166 ILE SER CYS TRP ASN ASP TYR GLY GLY TRP TYR ASP THR SEQRES 5 B 166 ASP HIS ILE ASN LEU VAL GLN GLY SER ALA PHE ALA GLY SEQRES 6 B 166 SER LEU GLN SER TYR LYS GLY SER LEU TYR TRP ASN ASN SEQRES 7 B 166 VAL THR TYR PRO PHE PRO LEU THR THR ASN THR ASN VAL SEQRES 8 B 166 LEU ASP ILE GLY ASP LYS THR PRO MET PRO LEU PRO LEU SEQRES 9 B 166 LYS LEU TYR ILE THR PRO VAL GLY ALA ALA GLY GLY VAL SEQRES 10 B 166 VAL ILE LYS ALA GLY GLU VAL ILE ALA ARG ILE HIS MET SEQRES 11 B 166 TYR LYS ILE ALA THR LEU GLY SER GLY ASN PRO ARG ASN SEQRES 12 B 166 PHE THR TRP ASN ILE ILE SER ASN ASN SER VAL VAL MET SEQRES 13 B 166 PRO THR GLY GLY HIS HIS HIS HIS HIS HIS HET SO4 A 201 5 HET 145 B 201 21 HETNAM SO4 SULFATE ION HETNAM 145 2-NITROPHENYL BETA-D-GALACTOPYRANOSIDE HETSYN 145 1-O-[O-NITROPHENYL]-BETA-D-GALACTOPYRANOSE; 2- HETSYN 2 145 NITROPHENYL BETA-D-GALACTOSIDE; 2-NITROPHENYL D- HETSYN 3 145 GALACTOSIDE; 2-NITROPHENYL GALACTOSIDE FORMUL 3 SO4 O4 S 2- FORMUL 4 145 C12 H15 N O8 FORMUL 5 HOH *263(H2 O) HELIX 1 AA1 GLY B 65 TYR B 70 5 6 SHEET 1 AA1 3 SER A 2 VAL A 5 0 SHEET 2 AA1 3 ILE A 40 TRP A 43 -1 O TRP A 43 N SER A 2 SHEET 3 AA1 3 MET A 100 PRO A 101 -1 O MET A 100 N CYS A 42 SHEET 1 AA2 4 GLY A 14 VAL A 20 0 SHEET 2 AA2 4 ARG A 142 SER A 150 1 O ASN A 147 N VAL A 18 SHEET 3 AA2 4 VAL A 124 ALA A 134 -1 N MET A 130 O PHE A 144 SHEET 4 AA2 4 ALA A 62 PHE A 63 -1 N ALA A 62 O ARG A 127 SHEET 1 AA3 5 GLY A 14 VAL A 20 0 SHEET 2 AA3 5 ARG A 142 SER A 150 1 O ASN A 147 N VAL A 18 SHEET 3 AA3 5 VAL A 124 ALA A 134 -1 N MET A 130 O PHE A 144 SHEET 4 AA3 5 ASP A 53 LEU A 57 -1 N HIS A 54 O ILE A 133 SHEET 5 AA3 5 LEU A 92 ILE A 94 -1 O LEU A 92 N ILE A 55 SHEET 1 AA4 4 LEU A 32 ASP A 35 0 SHEET 2 AA4 4 LEU A 104 THR A 109 -1 O LEU A 106 N VAL A 34 SHEET 3 AA4 4 LYS A 71 TRP A 76 -1 N SER A 73 O TYR A 107 SHEET 4 AA4 4 VAL A 79 PHE A 83 -1 O TYR A 81 N LEU A 74 SHEET 1 AA5 2 VAL A 117 ILE A 119 0 SHEET 2 AA5 2 VAL A 154 VAL A 155 -1 O VAL A 154 N VAL A 118 SHEET 1 AA6 3 SER B 2 VAL B 5 0 SHEET 2 AA6 3 ILE B 40 TRP B 43 -1 O TRP B 43 N SER B 2 SHEET 3 AA6 3 MET B 100 PRO B 101 -1 O MET B 100 N CYS B 42 SHEET 1 AA7 4 GLY B 14 VAL B 20 0 SHEET 2 AA7 4 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA7 4 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA7 4 ALA B 62 PHE B 63 -1 N ALA B 62 O ARG B 127 SHEET 1 AA8 5 GLY B 14 VAL B 20 0 SHEET 2 AA8 5 ARG B 142 SER B 150 1 O ASN B 147 N VAL B 18 SHEET 3 AA8 5 VAL B 124 ILE B 133 -1 N MET B 130 O PHE B 144 SHEET 4 AA8 5 ASP B 53 LEU B 57 -1 N ASN B 56 O TYR B 131 SHEET 5 AA8 5 LEU B 92 ILE B 94 -1 O LEU B 92 N ILE B 55 SHEET 1 AA9 4 LEU B 32 ASP B 35 0 SHEET 2 AA9 4 LEU B 104 THR B 109 -1 O ILE B 108 N LEU B 32 SHEET 3 AA9 4 LYS B 71 TRP B 76 -1 N TYR B 75 O LYS B 105 SHEET 4 AA9 4 VAL B 79 PHE B 83 -1 O TYR B 81 N LEU B 74 SHEET 1 AB1 2 VAL B 117 ILE B 119 0 SHEET 2 AB1 2 VAL B 154 VAL B 155 -1 O VAL B 154 N ILE B 119 SSBOND 1 CYS A 3 CYS A 42 1555 1555 2.03 SSBOND 2 CYS B 3 CYS B 42 1555 1555 2.03 CISPEP 1 GLY A 65 SER A 66 0 0.34 CISPEP 2 PHE A 83 PRO A 84 0 8.15 CISPEP 3 PHE B 83 PRO B 84 0 9.32 CISPEP 4 VAL B 111 GLY B 112 0 -5.80 CISPEP 5 GLY B 112 ALA B 113 0 -2.82 CRYST1 66.220 78.320 58.520 90.00 97.45 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015101 0.000000 0.001975 0.00000 SCALE2 0.000000 0.012768 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017234 0.00000